Abstract
The aims of this study were to evaluate the efficacy and tolerability of intravesical instillations of high-molecular-weight hyaluronic acid (HA) 1.6% and chondroitin sulfate (CS) 2.0% in patients with refractory painful bladder syndrome/interstitial cystitis (PBS/IC) and to observe their impact on Quality of Life. Twenty-three women were enrolled. They received bladder instillations with HA and CS weekly for 20 weeks and then monthly for 3 months. Mean follow-up after completion of therapy was 5 months. We observed a significant improvement in urinary symptoms on voiding diaries and Visual Analogue Scale for frequency (p = 0.045), urgency (p = 0.005), and pain (p = 0.001). The O’Leary–Sant Interstitial Cystitis Symptom Index and Interstitial Cystitis Problem Index resulted in a significant improvement in both scores (p = 0.004 and 0.01, respectively). The Pelvic Pain and Urgency/Frequency Symptom Scale only showed significant improvement in the symptom score (p = 0.001). This promising experience seems to offer an additional therapeutic option in patients with refractory PBS/IC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tait J (1994) Urethral syndrome (a bacterial cystitis) search for a pathogen. Br J Urol 57:552–556
Ochs RL et al (1994) Autoantibodies in interstitial cystitis. J Urol 151:587–592
Pang X (1995) Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 75:744–750
McGillis JP (1990) Immunomudulation by tachykinin neuropeptides. Ann N Y Acad Sci 594:85–94
Rosamilia A (1999) Activation of the kallikrein kinin system in interstitial cystitis. J Urol 162:129–134
McMahon SB (1996) NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci 351:431–440
Niku SD (1994) A new method for cytodestruction of bladder epithelium using protamine sulphate and urea. J Urol 152:1025–1028
Wesselmann U (1997) Mechanism of referred visceral pain: uterine inflammation in the adult virgin rat results in neurogenic plasma extravasation in the skin. Pain 73:309–317
Theodarides TC, Sant GR (2005) A pilot label study of Cystoprotek in interstitial cystitis. Int J Immunopathol Pharmacol 18(1):183–188
Morales A, Emerson L, Nickel JC (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:45–48
Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59(1):26–29
Kallenstrup EB, Joregensen S, Nordling J, Hald T (2005) Treatment of interstitial cystitis with Cystistat®: a hyaluronic acid product. Scand J Urol Nephrol 39:143–147
Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 140(1):203–206
Lewi H (1995) Cimetidine in the treatment of interstitial cystitis. Urology 45(6):1088
Lubeck DP, Witmore K, Sant GR, Alvares-Horine S, Lai C (2001) Psycometric validation of the O’Leary–Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology 57:62–66
Ito T, Tomoe H, Ueda T, Yoshimura N, Sant G, Hanno P (2003) Clinical symptoms scale for interstitial cystitis for diagnosis and for following the course of the disease. Int J Urol 10:S24
Evans RJ, Sant GR (2007) Current diagnosis of interstitial cystitis an evolving paradigm. Urology 69(Suppl 4):64–72
Toft BR, Nordling J (2006) Recent developments of intravesical therapy of painful bladder sindrome/interstitial cystitis: a review. Curr Opin Urol 16(4):268–272
Kho HC (2005) Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis. Urol Int 75(2):170–174
Parsons CL, Housely T, Schmidt JD et al (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73:504–7
Parsons CL (2005) Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 65(1):45–48
Leppilahti M, Hellstrom P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60(1):46–51
Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfluger H (2005) Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 47:393–397
Ahmad I, Sarath Krishna N, Meddings RM (2008) Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. Int Urogynecol J Pelvic Floor Dysfunct Sep 14 (in press)
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cervigni, M., Natale, F., Nasta, L. et al. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J 19, 943–947 (2008). https://doi.org/10.1007/s00192-008-0572-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-008-0572-4